Physician profile
Benjamin Matthew Wooster
NPI 1841618568
$188,781.51
in general payments reported to CMS, 2019-2025
20 companies · $73K in 2025
The $73K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,480 · 2020: $230 · 2021: $480 · 2022: $13K · 2023: $46K · 2024: $54K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $131K · Travel and Lodging: $35K · Food and Beverage: $7,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $131,200.00 |
| Travel and Lodging | $35,403.91 |
| Food and Beverage | $7,103.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $184,846.72 | 2019-2025 | Mako, Insignia, Triathlon |
| Heron Therapeutics, INC. | $1,128.40 | 2021-2025 | Zynrelef |
| Zimmer Biomet Holdings, INC. | $601.31 | 2022-2024 | Mymobility Platform, Persona |
| Smith+Nephew, INC. | $432.31 | 2021-2025 | Real Intelligence, Legion Revision, Pico |
| Encore Medical, Lp | $294.37 | 2020-2021 | |
| Osteoremedies, LLC | $220.91 | 2024 | Osteoboost Select 10cc, Biobrush, Biowash Surgical Irrigation |
| Medtronic, INC. | $191.82 | 2023-2024 | Plasmablade(Tm), Aquamantys(Tm) |
| Medacta USA, INC. | $176.26 | 2019-2022 | |
| Intellijoint Surgical INC. | $168.35 | 2024 | Intellijoint |
| Davol INC. | $160.13 | 2023 | Arista Ah Flexitip |
| Arthrex, INC. | $121.31 | 2019 | |
| Intuitive Surgical, INC. | $115.46 | 2025 | |
| Heraeus Medical, LLC. | $90.89 | 2025 | Palacos |
| Total Joint Orthopedics, INC. | $79.07 | 2020 | |
| Medical Device Business Services, INC. | $50.57 | 2019-2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $40.04 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $22.13 | 2025 | |
| Molnlycke Health Care US, LLC | $14.50 | 2025 | Mepilex Border Post-Op Ag |
| Ethicon US, LLC | $13.65 | 2022 | |
| Abbott Laboratories | $13.31 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Wooster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.